138 related articles for article (PubMed ID: 7508871)
1. Induction of apoptosis in murine ACTH-secreting pituitary adenoma cells by bromocriptine.
Yin D; Kondo S; Takeuchi J; Morimura T
FEBS Lett; 1994 Feb; 339(1-2):73-5. PubMed ID: 7508871
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in rat somatotrophin-secreting pituitary adenoma cells by bromocriptine.
Yin D; Kondo S; Takeuchi J; Morimura T
Oncol Res; 1993; 5(9):383-7. PubMed ID: 8038459
[TBL] [Abstract][Full Text] [Related]
3. Bromocriptine suppresses ACTH secretion from human pituitary tumour cells in culture by a dopaminergic mechanism.
Adams EF; Ashby MJ; Brown SM; White MC; Mashiter K
Clin Endocrinol (Oxf); 1981 Nov; 15(5):479-84. PubMed ID: 6276051
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Smad3 on Adrenocorticotropic Hormone-Secreting Pituitary Adenoma Development, Cell Proliferation, Apoptosis, and Hormone Secretion.
Zhou YZ; Li CZ; Gao H; Zhang YZ
World Neurosurg; 2018 Jun; 114():e329-e337. PubMed ID: 29524699
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2 gene prevents apoptosis in murine acth-secreting adenoma cells induced by bromocriptine.
Yin D; Kondo S; Takeuchi J; Morimura T; Vaux D
Int J Oncol; 1994 Jan; 4(1):187-91. PubMed ID: 21566911
[TBL] [Abstract][Full Text] [Related]
6. Bromocriptine-induced morphological changes in cultured growth hormone-producing pituitary adenoma cells.
Inoue A; Saito S; Kitamura H; Nakai O
Neurol Med Chir (Tokyo); 1989 Jan; 29(1):6-9. PubMed ID: 2472570
[TBL] [Abstract][Full Text] [Related]
7. Dopamine receptor D2S gene transfer improves the sensitivity of GH3 rat pituitary adenoma cells to bromocriptine.
Li Q; Su Z; Liu J; Cai L; Lu J; Lin S; Xiong Z; Li W; Zheng W; Wu J; Zhuge Q; Wu Z
Mol Cell Endocrinol; 2014 Jan; 382(1):377-384. PubMed ID: 24184771
[TBL] [Abstract][Full Text] [Related]
8. AT-101 acts as anti-proliferative and hormone suppressive agent in mouse pituitary corticotroph tumor cells.
Yurekli BS; Karaca B; Kisim A; Bozkurt E; Atmaca H; Cetinkalp S; Ozgen G; Yilmaz C; Uzunoglu S; Uslu R; Saygili F
J Endocrinol Invest; 2018 Feb; 41(2):233-240. PubMed ID: 28730425
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment with artesunate and bromocriptine has synergistic anticancer effects in pituitary adenoma cell lines.
Wang X; Du Q; Mao Z; Fan X; Hu B; Wang Z; Chen Z; Jiang X; Wang Z; Lei N; Wang H; Zhu Y
Oncotarget; 2017 Jul; 8(28):45874-45887. PubMed ID: 28501857
[TBL] [Abstract][Full Text] [Related]
10. Hypersecretion of gonadotropins by a pituitary adenoma: pituitary dynamic studies and treatment with bromocriptine in one patient.
Comtois R; Bouchard J; Robert F
Fertil Steril; 1989 Oct; 52(4):569-73. PubMed ID: 2806596
[TBL] [Abstract][Full Text] [Related]
11. Effects of bromocriptine on cell cycle distribution and cell morphology in cultured rat pituitary adenoma cells.
Johansen PW; Clausen OP; Haug E; Fossum S; Gautvik KM
Acta Endocrinol (Copenh); 1985 Nov; 110(3):319-28. PubMed ID: 4072574
[TBL] [Abstract][Full Text] [Related]
12. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
13. The effect of selective sst1, sst2, sst5 somatostatin receptors agonists, a somatostatin/dopamine (SST/DA) chimera and bromocriptine on the "clinically non-functioning" pituitary adenomas in vitro.
Gruszka A; Kunert-Radek J; Radek A; Pisarek H; Taylor J; Dong JZ; Culler MD; Pawlikowski M
Life Sci; 2006 Jan; 78(7):689-93. PubMed ID: 16115652
[TBL] [Abstract][Full Text] [Related]
14. Effect of bromocriptine and SMS 201-995 on growth of human somatotrophic and non-functioning pituitary adenoma cells in vitro.
Renner U; Mojto J; Lange M; Müller OA; von Werder K; Stalla GK
Eur J Endocrinol; 1994 Jan; 130(1):80-91. PubMed ID: 8124483
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of cabergoline on the development of estrogen-induced prolactin-secreting adenomas of the pituitary.
Dall'Ara A; Lima L; Cocchi D; Di Salle E; Cancio E; Devesa J; Müller EE
Eur J Pharmacol; 1988 Jun; 151(1):97-102. PubMed ID: 3416930
[TBL] [Abstract][Full Text] [Related]
16. Tumour ploidy in DNA histograms of pituitary adenomas.
Lüdecke DK; Beck-Bornholdt HP; Saeger W; Schmidt W
Acta Neurochir (Wien); 1985; 76(1-2):18-22. PubMed ID: 2988290
[TBL] [Abstract][Full Text] [Related]
17. A case of Cushing's disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism.
Tahara S; Kurotani R; Ishii Y; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 2002 Oct; 15(10):1102-5. PubMed ID: 12379758
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo.
Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M
Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha-2a is a potent inhibitor of hormone secretion by cultured human pituitary adenomas.
Hofland LJ; de Herder WW; Waaijers M; Zuijderwijk J; Uitterlinden P; van Koetsveld PM; Lamberts SW
J Clin Endocrinol Metab; 1999 Sep; 84(9):3336-43. PubMed ID: 10487708
[TBL] [Abstract][Full Text] [Related]
20. Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells.
Miller M; Chen S; Woodliff J; Kansra S
Endocrinology; 2008 Aug; 149(8):4158-67. PubMed ID: 18450960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
